1.Updates on biologic function of tumor suppressor gene inhibitor of growth family and related studies.
Chinese Journal of Pathology 2009;38(12):859-861
Animals
;
Apoptosis
;
Cell Cycle
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
physiology
;
DNA Repair
;
Homeodomain Proteins
;
genetics
;
metabolism
;
physiology
;
Humans
;
Inhibitor of Growth Protein 1
;
Intracellular Signaling Peptides and Proteins
;
genetics
;
metabolism
;
physiology
;
Neoplasm Metastasis
;
Neoplasms
;
metabolism
;
pathology
;
Neovascularization, Pathologic
;
pathology
;
Nuclear Proteins
;
genetics
;
metabolism
;
physiology
;
Prognosis
;
Receptors, Cytoplasmic and Nuclear
;
genetics
;
metabolism
;
physiology
;
Signal Transduction
;
Transcription Factors
;
genetics
;
metabolism
;
physiology
;
Tumor Suppressor Protein p53
;
metabolism
;
Tumor Suppressor Proteins
;
chemistry
;
genetics
;
metabolism
;
physiology
4.Study Progress of Haparanase in Kidney Diseases
Journal of Applied Clinical Pediatrics 1992;0(05):-
Heparanase(HPA) is an endo-beta-D-glucuronidase that degrades heparan sulfate proteoglycans side chains.Recently data suggested a role of HPA in several proteinuric diseases and an increased glomerular basement membrane.The research advanced of the molecular properties,the role in proteinuric diseases and the specific inhibitor of the human HPA were described.
7.Cytokine storm and liver failure
Zhi CHEN ; Haihong ZHU ; Ying YANG
Journal of Clinical Hepatology 2014;30(10):981-983
Cytokine storm plays an important role in the pathogenesis of liver failure.It is closely related to hepatocyte necrosis in the clini-cal course and the prognosis of this disease.With Kupffer cells as a clue,it is elucidated that related cells and cytokines influence each other and jointly function in the development and progression of liver failure,leading to serious liver tissue damage and necrosis.Cytokine -based research can help improve early diagnosis,disease assessment,and individualized treatment for liver failure.
8.Progress in nuclear molecular probes for noninvasive prostate cancer clinical imaging
Hua ZHU ; Zhen CHENG ; Zhi YANG
Chinese Journal of Nuclear Medicine and Molecular Imaging 2017;37(2):103-107
Prostate cancer (PCa) incidence is increasing in China.Because of the limited clinical symptoms,early detection of PCa is critical and difficult.Current clinical diagnostic methods for localizing PCa including both the conventional anatomic imaging and histological techniques have many problems.Enormous novel PCa specific molecular probes have been evaluated.Those probes have substantially improved the diagnostic accuracy and specificity of PCa.This review briefly introduces the conventional noninvasive imaging techniques for PCa diagnosis.Nuclear medicine probes that have great clinical value for PCa molecular imaging are also discussed.
9.Myogenic sarcoma of pulmonary vein: report of a case.
Tao ZHU ; Zhi-nong JIANG ; Mei JIN
Chinese Journal of Pathology 2011;40(5):346-347
Adult
;
Desmin
;
metabolism
;
Diagnosis, Differential
;
Female
;
Heart Neoplasms
;
pathology
;
Humans
;
Myxoma
;
pathology
;
Ovarian Neoplasms
;
secondary
;
surgery
;
Pulmonary Veins
;
Sarcoma
;
diagnostic imaging
;
metabolism
;
pathology
;
secondary
;
surgery
;
Tomography, X-Ray Computed
;
Vascular Neoplasms
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
10.Advances in human placenta-derived stem cells for liver regeneration
Jian WANG ; Zhengyan ZHU ; Zhi DU
Chinese Journal of Hepatobiliary Surgery 2013;(3):236-240
Human placenta-derived stem cells (hPD-SCs) are a mixed group of stem cells.Stem cell medicine has applications for organ damage or failure through regenerative,anti-apoptotic,anti-inflammatory and anti-tumor properties in addition to cell function recovery.Presently,human placenta mesenchymal stem cells (hPMSCs) have similar characteristics to the differentiation of hepatocyte-like cells by promoting hepatocyte regeneration,anti-hepatocyte apoptosis and anti-liver fibrosis,in vitro or in animal models.To further our investigation,a summary of the origin,sorting and biological properties of hPDSCs along with a narration of hPDSCs for liver disease therapy was written.This leads to a discussion for new ideas to further explore cell treatment for liver disease.